Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes

Area of Science:

• Neuroscience
• Psychiatry
• Medical Devices

Background:

• Current electroconvulsive therapy (ECT) devices use pulse amplitudes of 800-900 milliamperes (mA) without clear scientific justification.
• The pulse amplitude of ECT is a key determinant of the induced electric field magnitude in the brain.

Purpose of the Study:

• To investigate the effects of different pulse amplitudes on depression and cognitive outcomes in patients undergoing ECT.
• To determine if lower pulse amplitudes can maintain antidepressant efficacy while reducing neurocognitive side effects.

Main Methods:

• A double-blind study randomized patients with major depressive disorder (ages 50-80) to three ECT pulse amplitude arms: 600, 700, and 800 mA.
• Clinical, cognitive (including HVLT-R, Delis-Kaplan Executive Function System), and imaging assessments were performed before, during, and after ECT.

Main Results:

• Both 700 mA and 800 mA pulse amplitudes showed improved depression outcomes compared to the 600 mA arm.
• No significant differences in the primary cognitive outcome (HVLT-R retention) were observed across amplitude groups.
• The 800 mA group exhibited cognitive impairment in secondary measures, specifically Delis-Kaplan Executive Function System Letter and Category Fluency.

Conclusions:

• A dissociation exists between depression and cognitive outcomes related to ECT pulse amplitude, with higher amplitudes being more effective for depression but potentially causing more cognitive impairment.
• Findings suggest that optimizing ECT pulse amplitude may allow for a balance between antidepressant efficacy and cognitive preservation.
• Further research is needed to understand the complex relationship between ECT amplitude, electric fields, neuroplasticity, and clinical results.